HK1098450A1 - Process for preparing water soluble diterpenes and their applications - Google Patents

Process for preparing water soluble diterpenes and their applications

Info

Publication number
HK1098450A1
HK1098450A1 HK07104668.6A HK07104668A HK1098450A1 HK 1098450 A1 HK1098450 A1 HK 1098450A1 HK 07104668 A HK07104668 A HK 07104668A HK 1098450 A1 HK1098450 A1 HK 1098450A1
Authority
HK
Hong Kong
Prior art keywords
applications
water soluble
preparing water
diterpenes
soluble diterpenes
Prior art date
Application number
HK07104668.6A
Other languages
English (en)
Inventor
Muhammed Majeed
Arvind Kumar
Kalyanam Nagabhushanam
Subbalakshmi Prakash
Original Assignee
Sami Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami Labs Ltd filed Critical Sami Labs Ltd
Publication of HK1098450A1 publication Critical patent/HK1098450A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/92Naphthopyrans; Hydrogenated naphthopyrans
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
HK07104668.6A 2003-09-08 2007-05-02 Process for preparing water soluble diterpenes and their applications HK1098450A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/605,086 US6960300B2 (en) 2003-09-08 2003-09-08 Process for preparing water soluble diterpenes and their applications
PCT/US2004/028644 WO2005025500A2 (en) 2003-09-08 2004-09-02 Process for preparing water soluble diterpenes and their applications

Publications (1)

Publication Number Publication Date
HK1098450A1 true HK1098450A1 (en) 2007-07-20

Family

ID=34225859

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07104668.6A HK1098450A1 (en) 2003-09-08 2007-05-02 Process for preparing water soluble diterpenes and their applications

Country Status (14)

Country Link
US (2) US6960300B2 (zh)
EP (1) EP1718568B1 (zh)
JP (1) JP5021305B2 (zh)
CN (1) CN1882508B (zh)
AU (1) AU2004272005B2 (zh)
BR (1) BRPI0413957A (zh)
CA (1) CA2537820C (zh)
EA (1) EA012836B1 (zh)
HK (1) HK1098450A1 (zh)
MX (1) MXPA06002684A (zh)
NZ (1) NZ545765A (zh)
RS (1) RS20060169A (zh)
WO (1) WO2005025500A2 (zh)
ZA (1) ZA200601898B (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060122261A1 (en) * 2003-11-20 2006-06-08 Muhammed Majeed [method of preparing labdane diterpene composition, preferably isoforskolin and deacetylforskolin from forskolin extract and their use for promoting lean body mass and other applications]
US20110077292A1 (en) * 2004-07-01 2011-03-31 Biotest Laboratories, Llc. Forskolin carbonates and uses thereof
JP2007210988A (ja) * 2006-02-07 2007-08-23 Sabinsa Corp ジテルペンフォルスコリン及びその誘導体で男性ホルモン及び女性ホルモンを生理学的に増大するための組成物
US20080181877A1 (en) * 2006-03-22 2008-07-31 Leangene Ab, C/O Cit Ekonomiservice Ab Method For Monitoring the Effect of Compounds on Foxc2 Expression
US20080226571A1 (en) * 2007-03-16 2008-09-18 Muhammed Majeed Compositions and methods to effect enhanced photoprotection against UV A and UV B induced damage of human skin
US20080241285A1 (en) * 2007-04-01 2008-10-02 Muhammed Majeed Compositions and Methods to Treat Alopecia
WO2009110009A2 (en) * 2008-03-07 2009-09-11 Sun Pharma Advanced Research Company Ltd., Opthalmic composition
US20100076069A1 (en) * 2008-09-22 2010-03-25 Muhammed Majeed Forskolin dosing regimen in open angle glaucoma and patient compliance methods thereof
WO2011043630A2 (ko) * 2009-10-08 2011-04-14 (주)송호바이오메드 고 수용성 2-하이드록시프로필-베타사이클로덱스트린을 유효성분으로 함유하는 비만 질환 예방 및 치료용 조성물
WO2011053979A1 (en) * 2009-11-02 2011-05-05 Nupathe, Inc. Methods for treating parkinson's disease
CA2820984C (en) * 2010-12-09 2016-10-11 Indus Biotech Private Limited A complex of garcinol, cyclodextrin and method thereof
CN103588745B (zh) * 2013-11-26 2015-10-28 陕西嘉禾植物化工有限责任公司 一种从毛喉鞘蕊花中提取和分离弗斯可林的方法
WO2017103840A1 (en) * 2015-12-16 2017-06-22 MOHAMED ABDULLA ANZAR, Cheppattu A water soluble 10% w/w forskolin composition and a method of synthesizing the same
WO2018000093A1 (en) 2016-06-30 2018-01-04 Plume Cosmetics Inc. Composition and method for promoting eyelash and eyebrow growth exclusively containing naturally sourced ingredients
HUE054617T2 (hu) * 2017-01-09 2021-09-28 Scipharm S A R L Új eljárás vízoldható forskolin elõállítására
WO2018235939A1 (ja) * 2017-06-23 2018-12-27 Tkヘルスリサーチ株式会社 包接化された抗酸化物質を含む眼科用組成物ならびにその使用
JP7004968B2 (ja) 2017-10-06 2022-01-21 青葉化成株式会社 食用の徐放性機能材の製造方法
CN108651819A (zh) * 2018-05-18 2018-10-16 南昌大学 一种稳定态全谷物超微粉速食粉的制备方法
WO2020179503A1 (ja) * 2019-03-01 2020-09-10 長谷川香料株式会社 セスキテルペン酸素付加体の製造方法、化合物および組成物
WO2020186235A1 (en) 2019-03-14 2020-09-17 The Broad Institute, Inc. Compositions and methods for modulating cgrp signaling to regulate intestinal innate lymphoid cells
HUE065181T2 (hu) 2020-01-23 2024-05-28 Scipharm S A R L 7-deacetilforskolin és PVP komplexe
KR20220149987A (ko) * 2021-05-03 2022-11-10 연세대학교 산학협력단 안구건조증 또는 안구건조증 연관 안과 질환의 예방, 개선 또는 치료용 조성물
CN117586217B (zh) * 2024-01-17 2024-03-19 云南省药物研究所 一种基于国产毛喉鞘蕊花的佛司可林制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
US4476140A (en) * 1983-05-16 1984-10-09 Yale University Composition and method for treatment of glaucoma
US6407079B1 (en) * 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
HU199444B (en) * 1985-09-10 1990-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom
US5070209A (en) * 1986-11-20 1991-12-03 Hoechst Roussel Pharmaceuticals Inc. 12-halogenated forskolin derivatives
US5302730A (en) * 1987-06-29 1994-04-12 Nippon Kayaku Kk Process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
US5846992A (en) * 1987-10-08 1998-12-08 Hoechst Marion Roussel, Inc. Synergistic intraocular pressure lowering combinations
ES2037385T3 (es) * 1988-01-14 1993-06-16 Akzo N.V. Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
IL89530A0 (en) * 1989-03-08 1989-09-10 Jeffrey J Feigenbaum Compositions containing forskolin
US5376645A (en) * 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
JP3040015B2 (ja) * 1991-08-21 2000-05-08 日研化学株式会社 フォルスコリンの包接化合物
TW422696B (en) * 1995-03-20 2001-02-21 Katsuhiko Mukai Ophthalmic composition containing active vitamin D
US6471972B1 (en) * 1996-11-07 2002-10-29 Lvmh Recherche Cosmetic treatment method for fighting against skin ageing effects
US5804596A (en) * 1997-02-27 1998-09-08 Sabinsa Corporation Method of preparing a forskohlin composition from forskohlin extract and use of forskohlin for promoting lean body mass and treating mood disorders
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
IT1294205B1 (it) * 1997-07-23 1999-03-24 Farmigea Spa Procedimento per la solubilizzazione in acqua e in veicoli acquosi di sostanze farmacologicamente attive
US6540895B1 (en) * 1997-09-23 2003-04-01 California Institute Of Technology Microfabricated cell sorter for chemical and biological materials
US6699849B1 (en) * 1998-02-23 2004-03-02 Cyclops, Ehf. Cyclodextrin complexes of benzodiazepines
US6645994B1 (en) * 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
EP1443969A2 (en) * 2001-10-18 2004-08-11 Decode Genetics EHF Non-inclusion cyclodextrin complexes
EP2277551B1 (en) * 2002-09-06 2013-05-08 Cerulean Pharma Inc. Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto

Also Published As

Publication number Publication date
US6960300B2 (en) 2005-11-01
JP5021305B2 (ja) 2012-09-05
AU2004272005B2 (en) 2011-03-10
RS20060169A (en) 2008-08-07
EA200600528A1 (ru) 2006-08-25
EP1718568A4 (en) 2009-01-07
EA012836B1 (ru) 2009-12-30
CA2537820C (en) 2013-03-26
US20050284812A1 (en) 2005-12-29
BRPI0413957A (pt) 2006-10-31
WO2005025500A3 (en) 2005-06-09
JP2007505040A (ja) 2007-03-08
MXPA06002684A (es) 2007-03-15
EP1718568A2 (en) 2006-11-08
NZ545765A (en) 2009-11-27
CA2537820A1 (en) 2005-03-24
CN1882508A (zh) 2006-12-20
CN1882508B (zh) 2010-07-14
US20050051483A1 (en) 2005-03-10
EP1718568B1 (en) 2012-12-26
ZA200601898B (en) 2008-09-25
WO2005025500A2 (en) 2005-03-24
AU2004272005A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
ZA200601898B (en) Process for preparing water soluble diterpenes and their applications
TWI370145B (en) Water-soluble polyhydroxyaminoether and process for preparing the same
IL175363A0 (en) Urea derivative and process for preparing the same
TWI349672B (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
PL1756257T3 (pl) Sposób wytwarzania wyrobów rozpuszczalnych w wodzie i takie wyroby
EP1638486A4 (en) OSTEOIMPLANTATES AND METHOD FOR THE PRODUCTION THEREOF
HK1097734A1 (en) 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
PL1633876T3 (pl) Sposoby wytwarzania insuliny w roślinach
HK1089768A1 (en) Indolone-acetamide derivatives, processes for preparing them and their uses
GB0306179D0 (en) Piping
GB2426704B (en) Herbal oro-dental care composition and process for preparing the same
GB0303659D0 (en) Process
IL174975A0 (en) 2-phenyl-benzofuran derivatives, method for the production thereof and their use
GB0306657D0 (en) Process and compounds
PT1663997E (pt) 1h-azolilmetilamidas, processos para a sua produção e a sua utilização como inibidores de nitrificação
EP1591440A4 (en) ALANINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE
PL372197A1 (en) Water soluble phenylglycine derivatives
GB0317393D0 (en) Process and compounds
AM1402A2 (en) Hardtack preparing method
AU2003282430A8 (en) Photocatalyst composition and preparing method thereof
GB0300733D0 (en) Process
GB2393689B (en) Ornament
GB2412373B (en) Process for preparing guggulsterones
IL174672A0 (en) Water soluble nanoparticles and method for their production
IL156838A0 (en) Veterinary herbal composition and preparing process

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220826